Screener
Protagonist Therapeutics PTGX Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
FAQ
- What is Protagonist Therapeutics's invested capital?
- Protagonist Therapeutics (PTGX) reported invested capital of $430.68M in Q2 2026.
- How has Protagonist Therapeutics's invested capital changed year-over-year?
- Protagonist Therapeutics's invested capital decreased by 15.7% year-over-year, from $510.75M to $430.68M.
- What is the long-term trend for Protagonist Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's invested capital has grown at a 24.2% compound annual growth rate (CAGR), from $168.21M to $496.64M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Protagonist Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude